David R. Wells was named Chief Financial Officer of Fusemachines Inc., effective August 30, 2026. As of November 6, 2026, Fusemachines Inc. has reported 3 leadership change filings to the SEC under Item 5.02 of Form 8-K, from June 1, 2026 to September 4, 2026, naming 3 appointments and 1 departure (Form 8-K, September 4, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Fusemachines Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · In / out: In · Person: David R. Wells · Role: Chief Financial Officer · Effective: 2026-08-30 · 8-K, 2026-09-04
- · In / out: In · Person: Sameer Maskey · Role: Chief Financial Officer · 8-K, 2026-08-07
- · In / out: In · Person: Julia Hirschberg · Role: Director · Effective: 2026-05-31 · 8-K, 2026-06-01
Fusemachines Inc. reported changes in 3 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-06-01 to 2026-09-04. They name 4 people, with 3 appointments and 1 departure. Every row below is cited to the filing it comes from, and this page adds each new change as Fusemachines Inc. files it.
Also on the record for Fusemachines Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| February 2, 2026 | Stake report, Schedule 13G/A, by Jonathan Binder | 15.5% of the class | 5%+ stakes | Source |
| February 2, 2026 | Stake report, Schedule 13G/A, by Jonathan Binder | 18.91% of the class | 5%+ stakes | Source |
| January 15, 2026 | Stake report, Schedule 13G/A, by CONSILIUM FRONTIER EQUITY FUND LP | 17.03% of the class | 5%+ stakes | Source |
| December 12, 2025 | Stake report, Schedule 13G, by CONSILIUM EXTENDED OPPORTUNITIES FUND LP | 14.4% of the class | 5%+ stakes | Source |
| December 12, 2025 | Stake report, Schedule 13G, by CONSILIUM FRONTIER EQUITY FUND LP | 15.9% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Fusemachines Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Fusemachines Inc. and the records around it.
Fusemachines Inc. elsewhere on the record
- 5%+ stake filings Feb 2026
- Who owns it
Watch Fusemachines Inc.
Get an email when Fusemachines Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Fusemachines Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Fusemachines Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Fusemachines Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
8 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-09-04 | In | Chief Financial Officer | 2026-08-30 | 8-K, 2026-09-04 | |
| 2026-08-07 | In | Chief Financial Officer | 8-K, 2026-08-07 | ||
| 2026-06-01 | In | Director | 2026-05-31 | 8-K, 2026-06-01 | |
| 2026-06-01 | Out | Director | 8-K, 2026-06-01 |
Who leads Fusemachines Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Financial Officer: David R. Wells, appointed, effective 2026-08-30 (filed 2026-09-04).
- Director: Sanjay Shrestha, departure reported (filed 2026-06-01). No successor is named in these filings.
New leaders reset buying decisions — get the Full Report on Fusemachines Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Financial Officer at Fusemachines Inc., with the record behind each one.
Find candidates like Chief Financial Officer at Fusemachines Inc.Every change, in the filing's words
Appointed: David R. Wells, Chief Financial Officer, effective 2026-08-30
Appointment of David R. Wells as Consulting Chief Financial Officer On September 1, 2026, the Board of Directors (the "Board") of Fusemachines Inc., a Delaware corporation (the "Company"), appointed David R. Wells as the Company's Consulting Chief Financial Officer, Principal Financial Officer, and Principal Accounting Officer, effective as of August 30, 2026.
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers.
- Mr. Wells, age 64, has more than 30 years of experience in finance, operations and administrative positions, primarily with medical and technology companies.
- Since July 2021, Mr. Wells has been the owner of Atlas Bookkeeping, LLC, a Nevada corporation ("Atlas") where he provides CFO-level advisory services to public and private companies.
- Since December 2025, Mr. Wells has served as an Advising CFO to Functional Brands Inc., (OTC Markets: MEHA) providing CFO guidance following the company's listing on Nasdaq and subsequent listing on the OTC Markets.
- From August 2023 to May 2025, Mr. Wells served as Chief Financial Officer of Envoy Medical, Inc. (Nasdaq: COCH), where he provided strategic CFO guidance following the company's deSPAC transaction.
- From June 2021 to September 2022, Mr. Wells served as Chief Financial Officer of GHS Investments, LLC, a private equity fund.
- Since December 2022, Mr. Wells has served as a member of the Board of Directors of HeartSciences, Inc. (Nasdaq: HSCS).
- Mr. Wells has a bachelor's degree in finance and entrepreneurship from Seattle Pacific University and a master of business administration from Pepperdine Graziadio Business School.
Appointed: Sameer Maskey, Chief Financial Officer
Sameer Maskey, the Company's Chief Executive Officer, will assume the role of principal financial officer and principal accounting officer effective as of the Separation Date, on an interim basis until a successor Chief Financial Officer is appointed.
- Christine Chambers, Chief Financial Officer of Fusemachines Inc., a Delaware corporation (the "Company") is departing from the Company, effective August 31, 2026 (the "Separation Date") to pursue new opportunities.
- Ms. Chambers indicated to the Company that her separation was not a result of any disagreement with the Company, the Company's board of directors, or the Company's management on any matter relating to the Company's operations, policies, or practices.
- The Company is commencing a search for a successor Chief Financial Officer.
- Exhibit Number Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document.)
Appointed: Julia Hirschberg, Director, effective 2026-05-31
Effective May 31, 2026, the board of directors (the "Board") of Fusemachines Inc., a Delaware corporation (the "Company" or "Fusemachines"), following the recommendation of the Nominating and Corporate Governance Committee of the Board (the "Nominating Committee"), appointed Julia Hirschberg as a member of the Board as a Class II director, until the Company's 2027 annual meeting of stockholders or until Ms. Hirschberg's successor is duly elected and qualified.
Departing: Sanjay Shrestha, Director
On May 31, 2026, in connection with the appointment of Ms. Hirschberg, Sanjay Shrestha resigned as a member of the Board, as the chair of the Compensation Committee, and as a member of each of the Audit Committee and the Nominating Committee.
- Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
- Ms. Hirschberg was also appointed as a member of each of the Audit Committee of the Board (the "Audit Committee"), the Compensation Committee of the Board (the "Compensation Committee") and the Nominating Committee.
- Ms. Hirschberg was also appointed as chair of the Compensation Committee.
- Ms. Hirschberg, age 79, is the Percy K. and Vida L. W. Hudson Professor of Computer Science at Columbia University, a position she has held since 2002, and previously served as Chair of the Computer Science Department from 2012 to 2018.
- She received her PhD in Computer Science from the University of Pennsylvania.
- Prior to joining Columbia, Ms. Hirschberg worked at Bell Laboratories and AT&T Laboratories - Research from 1985 to 2003, serving as a Member of Technical Staff, Division Manager and Technology Leader, and creating the Human-Computer Interface Research Department.
- Ms. Hirschberg also served as a Guest Professor at the Royal Institute of Technology (KTH) in Stockholm from 2008 to 2009.
- She co-chaired the Computing Research Association's Committee on Women from 2016 to 2019, was an Amazon Scholar from 2020 to 2025.
Tools for this story
Each opens in a new tab, filled in for Fusemachines Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.